Healius Ltd traded at 3.03 this Friday December 2nd, increasing 0.11 or 3.77 percent since the previous trading session. Looking back, over the last four weeks, Healius Ltd gained 10.36 percent. Over the last 12 months, its price fell by 34.70 percent. Looking ahead, we forecast Healius Ltd to be priced at 3.28 by the end of this quarter and at 3.03 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
Daily Change

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Peers Price Day Year
Ansell 28.89 0.12 0.42% -8.69%
Capitol Health Ltd 0.32 0 0% -11.11%
Cochlear 215.48 2.48 1.16% 1.96%
CSL 301.89 3.23 1.08% 1.42%
Fisher Paykel Healthcare 24.05 -0.27 -1.11% -25.26%
Integral Diagnostics Ltd 2.71 -0.05 -1.81% -41.72%
Mayne Pharma 0.24 0 0% -11.11%
Nanosonics Ltd 4.86 0.02 0.41% -9.16%
Polynovo Ltd 1.99 -0.04 -1.97% 41.64%
Ramsay Health Care 66.15 0.31 0.47% -1.14%
ResMed 34.10 0.55 1.64% -5.51%
Sonic Healthcare 32.19 0.39 1.23% -24.47%
Sigma Healthcare Ltd 0.63 -0.01 -0.79% 19.05%

Indexes Price Day Year
AUALL 7504 -50.50 -0.67% -0.53%
AU200 7302 -52.90 -0.72% 0.83%

Healius Ltd
Healius Limited is an Australia-based healthcare company. The Company operates through three segments: Pathology, Imaging and Day Hospitals. Pathology segment provides pathology services. Imaging segment offers imaging and scanning services from imaging sites, hospitals and from within the consolidated entity's medical centers. Day Hospitals segment is an operator of day hospitals and hematology or oncology services and provides services and facilities to In-Vitro Fertilization (IVF) specialists. The Company also provides facilities and support services to general practitioners, radiologists and a range of other healthcare professionals, enabling them to care their patients in partnership with the Company's pathologists, nurses and other employees.